Navigation Links
Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal,,,Fibroblasts

Improve transfection of primary cells up to 20-fold with Primary ENHANCER reagent

David Staggs
Genetic Applications LLC

Peter Pingerelli

Stratagenes Primary ENHANCER transfection reagent promotes efficient transfection of human dermal fibroblasts. Twenty minutes before transfection, cells are incubated in media containing the Primary ENHANCER reagent. After incubation, lipid or calcium phosphate (CaPO4)-mediated transfection can be performed using standard protocols. In earlier results, Primary ENHANCER reagent increased transfection efficiencies of some primary cell strains as high as 15-fold.1 In this study, we compared its effects on lipid- and CaPO4-mediated transfection using Stratagenes Normal Human Dermal Fibroblasts.

Human dermal fibroblasts are used to investigate many disease processes, including cancer, skin ulcers, collagen diseases, and scleroderma. They are also valuable for studying wound healing, growth factors, artificial skin, and dermal toxicity.

To study gene expression, a common approach usually involves introducing exogenous DNA into cells using transfection techniques in order to investigate the effects of resulting proteins. Unfortunately, primary human fibroblasts are difficult to transfect. However, with Stratagenes Human Dermal Fibroblasts, the method with which to study molecular and biochemical mechanisms in this system is improved. Additionally, Stratagenes new Primary ENHANCER reagent improves the transfection efficiency of lipid- or CaPO4-mediated transfection of human dermal fibroblasts.

Easily Increased Transfection

We grew Stratagenes Human Dermal Fibroblasts, which are isolated from adult skin and cryopreserved in vials (500,00 cells/vial),2 for two passages in standard growth media. The cells were then plated in 24-well format tissue culture dishes and allowed to attach for 18 hours. The media was replaced with media containing 0, 10, or 40 M of Stratagenes Primary ENHANCER reagent. After 20 minutes, the cells were transfected with a plasmid expressing the b-galactosidase reporter molecule under the control of the cytomegalovirus promoter (pCMVbGAL). Transfection was performed using either Stratagenes LipoTAXI transfection reagent3 or a CaPO4-mediated transfection technique.4

The Primary ENHANCER reagents effects on lipid-mediated transfection show that expression of the reporter molecule improved over 5-fold after incubating in 10 M Primary ENHANCER reagent and 20-fold after incubating in 40 M Primary ENHANCER reagent (Figure 1). Results were measured by Stratagenes fluorescent b-galactosidase assay kit.

Figure 1

The Primary ENHANCER reagents effects from using a CaPO4-mediated transfection technique show that expression of the reporter molecule, b-galactosidase, improved slightly after incubating in 10 M Primary ENHANCER reagent and nearly 3-fold after incubating in 40 M Primary ENHANCER reagent (Figure 2). Results were measured by Stratagenes fluorescent b-galactosidase assay kit.

Figure 2


Use Stratagenes Human Dermal Fibroblasts to study molecular and biochemical mechanisms in human fibroblasts. We demonstrated that the transient transfection of fibroblasts improved up to 20-fold in lipid-mediated transfection and nearly 3-fold in CaPO4-mediated transfection, using Stratagenes Primary ENHANCER reagent. When the need arises to transfect human fibroblasts, add the Primary ENHANCER reagent to a lipid-mediated or CaPO4-mediated transfection technique, and achieve optimal results.


1. Halvorsen, Y.C., et al. (1998) Strategies 11: 58-60.
2. See package insert.
3. Petre, M., et al. (1998) Strategies 11: 88-90.
4. Ausubel F.M., et al., (1994) In Current Protocols in Molecular Biology. John Wiley & Sons, New York, NY.



Page: All 1 2 3

Related biology technology :

1. The Best Enzyme for the Toughest PCR Challenges Improved with New Hot-Start Feature
2. Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase
3. Improved Sensitivity for Staining RNA with SYBR Gold Stain
4. Improved Vectors for PathDetect Trans-Reporting Systems
5. Improve Amplification Specificity with Hot Start PCR Enzyme
6. Improved Quantitative Selectivity of Clenbuterol in Human Urine using High Resolution on the TSQ Quantum Mass Spectrometer
7. Gene Expression Arrays: Highly Sensitive Detection of Expression Patterns with Improved Tools for Target Amplification
8. Improve RNA Isolation for Array Analysis and More
9. Protect RNA and Improve Target Cell Identification
10. The Worlds Best DNase Improved TURBO DNA-free
11. Improve Recovery and Reproducibility with Pre-Treatment of Analytical TSK-GEL G3000SWXL Size Exclusion Columns
Post Your Comments:

(Date:11/26/2015)... CHESHAM , England , November 26, ... Lightpoint Medical, an innovative medical device company specializing in ... Euro grant from the European Commission as part of the ... enabling the company to carry out a large-scale clinical trial ... -->      (Logo: , ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... Studies reveal the differences in species of ... way for more effective treatment for one of the most ... --> --> Gum disease is ... yet relatively little was understood about the bacteria associated with ... by researchers from the WALTHAM Centre for Pet Nutrition together ...
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
Breaking Biology Technology:
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
(Date:11/4/2015)... 4, 2015 --> ... published by Transparency Market Research "Home Security Solutions Market - ... 2015 - 2022", the global home security solutions market is expected ... 2022. The market is estimated to expand at a ... to 2022. Rising security needs among customers at homes, ...
Breaking Biology News(10 mins):